Terms: = Sarcomas AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3 AND Prognosis
4 results:
1. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
Li T; Tang Z; Li S; Lu M
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
[TBL] [Abstract] [Full Text] [Related]
2. Identification of ATG7 as a Regulator of Proferroptosis and Oxidative Stress in Osteosarcoma.
Jiang R; He S; Gong H; Wang Y; Wei W; Chen J; Hu J; Ye C; LiuHuang S; Jin S; Wei H; Xu W; Xiao J
Oxid Med Cell Longev; 2022; 2022():8441676. PubMed ID: 36254233
[TBL] [Abstract] [Full Text] [Related]
3. Outstanding prognostic value of novel ferroptosis-related genes in chemoresistance osteosarcoma patients.
Zhao J; Zhao Y; Ma X; Feng H; Jia L
Sci Rep; 2022 Mar; 12(1):5029. PubMed ID: 35322804
[TBL] [Abstract] [Full Text] [Related]
4. Expression of cyclin-dependent kinase inhibitor p27/Kip1 and AP-1 coactivator p38/jab1 correlates with differentiation of embryonal rhabdomyosarcoma.
Tsuchida R; Miyauchi J; Shen L; Takagi M; Tsunematsu Y; Saeki M; Honna T; Yamada S; Teraoka H; Kato JY; Mizutani S
Jpn J Cancer Res; 2002 Sep; 93(9):1000-6. PubMed ID: 12359053
[TBL] [Abstract] [Full Text] [Related]